IL6 and type 2 diabetes mellitus: Current studies used macrophage-derived factors or surface markers, including TNF-α, IL-1β, IL-6, miRNAs, and folate receptor (FR), as the therapeutic targets for diabetes, which have potential to be developed as pharmacological targets for the treatment of T2D [225,226].